GPNMB and neurodegenerative disease: In terms of neurodegenerative diseases, the levels of GPNMB are elevated in brain samples of sporadic AD patients and in the substantia nigra of sporadic Parkinson’s disease patient brains (Hüttenrauch et al, 2018; Moloney et al, 2018).